1,1-DIMETHYLETHYL 2,4,6-TRIDEOXY-3,5-O-(1-METHYLETHYLIDENE)-6-((5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFONYL)-D-ERYTHRO-HEXONATE
UNII 52EH5JG2X5
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,1-dimethylethyl 2,4,6-trideoxy-3,5-o-(1-methylethylidene)-6-((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)-d-erythro-hexonate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 52EH5JG2X5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1326302-97-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H26N2O6S2 MDPVYOZJHFEALS-NEPJUHHUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,1-dimethylethyl 2,4,6-trideoxy-3,5-o-(1-methylethylidene)-6-((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)-d-erythro-hexonate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.